000 | 01612 a2200433 4500 | ||
---|---|---|---|
005 | 20250514204559.0 | ||
264 | 0 | _c20041119 | |
008 | 200411s 0 0 eng d | ||
022 | _a0021-972X | ||
024 | 7 |
_a10.1210/jc.2004-0446 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZeender, E | |
245 | 0 | 0 |
_aPioglitazone and sodium salicylate protect human beta-cells against apoptosis and impaired function induced by glucose and interleukin-1beta. _h[electronic resource] |
260 |
_bThe Journal of clinical endocrinology and metabolism _cOct 2004 |
||
300 |
_a5059-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aGlucose _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 |
_aInsulin _xmetabolism |
650 | 0 | 4 | _aInsulin Secretion |
650 | 0 | 4 |
_aInterleukin-1 _xmetabolism |
650 | 0 | 4 |
_aIslets of Langerhans _xcytology |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 | _aPioglitazone |
650 | 0 | 4 |
_aSodium Salicylate _xpharmacology |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
700 | 1 | _aMaedler, K | |
700 | 1 | _aBosco, D | |
700 | 1 | _aBerney, T | |
700 | 1 | _aDonath, M Y | |
700 | 1 | _aHalban, P A | |
773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 89 _gno. 10 _gp. 5059-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2004-0446 _zAvailable from publisher's website |
999 |
_c15163733 _d15163733 |